Quartet Lead and Resynchronization Therapy Options

Abbott Medical Devices51 enrolled

Overview

The purpose of this Clinical Trial is to determine the percentage of patients whose hemodynamic response improves with the different configurations offered by the new Quartet® left ventricular lead, as a result of its four electrodes, with respect to the configurations offered by a standard bipolar lead. Furthermore, the optimal stimulation configuration will be determined from a comparison with traditional configurations.

This is a prospective, non-randomised, multi-centre, national, interventional clinical trial of a medical device. This trial involves two visits: one at the beginning of the study, which will be undertaken in the seven days following implant, and another visit at 6 months after enrollment. It is recommended that the enrollment visit is undertaken as soon as possible after implantation, although the time window allows the timing to be adapted to each centre's standard practice. Resynchronization therapy in those patients suitable for participation in this trial is expected to begin once this enrollment visit has been completed. Once data collection at enrollment visit has been completed, final device programming will be based on each investigator's criteria and will be undertaken following the standard practice of each centre.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Heart Failure

Interventions

Cardiac Resynchronization Therapy DefibrillatorDEVICE

Cardiac Resynchronization Therapy Defibrillator

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients with a Cardiac resynchronization Therapy Defibrillator device (CRT-D) and a Quartet® quadripolar electrode from St Jude Medical (used in "Single Site Pacing" mode) implanted in the left ventricle. 2. Patients who have provided written informed consent 3. Patients who are in sinus rhythm. 4. Patients older than 18 years of age. Exclusion Criteria: 1. Patients in atrial fibrillation at the time of the echocardiographic study of the enrollment visit. 2. Patients with valvular disease. 3. Patients in functional class New York Heart Association (NYHA) IV 4. Patients for whom echocardiography images suitable for determining the cardiac output cannot be obtained. 5. Patients whose device has been changed/upgraded. 6. Pregnant patients. 7. Patients who do not fulfill all the inclusion criteria. 8. Patients who are unable to provide written informed consent

Locations (1)

Hospital Clínico Universitario Virgen de la Victoria

Málaga, Spain

Outcomes

Primary Outcomes

Number of Patients Whose Cardiac Output (CO) Value in Acute, as Measured Echocardiographically, Improves With the Different Stimulation Vectors Offered by the Quartet® Left Ventricular Electrode.

Time frame: Enrollment visit (in the seven days after implantation of the device)

Secondary Outcomes

Percent Difference Between the Best CO From Non-traditional Vectors and Best CO From Traditional Vectors

In patients with best CO obtained from Non-traditional, to calculate the percent difference between the best CO from Non-traditional vectors and best CO from Traditional vectors, vectors.This percentage was the CO from Non-traditional vectors minus CO from Traditional vectors then divided by CO from Traditional vectors. The Quartet® lead has 4 poles: Distal (D1), Mid 2 (M2), Mid 3 (M3) and Proximal (P4). The 3 Traditional vectors are the traditional configurations available in a standard bipolar lead: D1-M2, D1-Right Ventricular Coil (RVC) and M2-RVC. The 7 Non-traditional vectors are the additional configurations available in a Quartet® lead: D1-P4, M2-P4, M3-M2, M3-RVC, M3-P4, P4-M2 and P4-RVC.

Time frame: At enrollment

Cardiac Output (CO) With Different Configurations at Enrollment

Means of baseline non-paced CO, best CO obtained from traditional configurations and best CO obtained from all quadripolar configurations at enrollment.

Time frame: Enrollment visit (in the seven days after implantation of the device)

Capture Threshold

Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied. Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.

Time frame: Enrollment visit (in the seven days after implantation of the device)

Capture Threshold

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.